Abstract
This description of drugs, doses, and other information is provided for study. Broad knowledge of the drug, the protocol (drug dosages vary a lot according to different protocols), toxicity, dose adjustment, patient monitoring, and other pertinent aspects is necessary before prescribing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taketomo C, Hodding J, Kraus D. Pediatric & neonatal dosage handbook. 21st ed. Hudson: Lexicomp; 2014.
Schmidt CWP, Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2016.
McLeod HL, Relling MV, Crom WR, et al. Disposition of antineoplastic drugs agents in the very young child. Br J Cancer Suppl. 1992;18:S23–9.
Veal GJ, Errington J, Hayden J, et al. Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer. 2015;51(14):2022–30.
Veal GJ, Errington J, Sastry J, et al. Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer Chemother Pharmacol. 2016;77:685–92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819938.
Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. 2015;3:37.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Penteado Schmidt, C.W. (2018). Peculiarities of Most Commonly Used Chemotherapy Drugs in Neonates and Infants. In: Chemotherapy in Neonates and Infants. Springer, Cham. https://doi.org/10.1007/978-3-319-70591-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-70591-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70590-3
Online ISBN: 978-3-319-70591-0
eBook Packages: MedicineMedicine (R0)